"Sadly people with diabetes are at much greater risk of developing complications like footulcers, infections and nerve damage, " Diabetes UK clinical adviser Zoe Harrison said.
Another drug, from the African clawed frog, from GlaxoSmithkline and a small biotech company was rejected in 1999 by the FDA as a treatment for diabetic footulcers.